| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |